The Effect of Exercise on Hepatic Glucose Metabolism
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
It is known that obesity and/or physical inactivity greatly increase a person's risk of developing heart disease and other serious health problems. This is partly because diabetes is associated with inflammation, oxidative stress, and insulin resistance. Diabetes is also associated with high levels of triglycerides in the blood and tissues such as the liver (known as fatty liver or steatosis). This elevation of fat in the liver is known to cause liver insulin resistance and impair the function of the liver and this impairment contributes to the development of diabetes.
Studies have shown that both aerobic exercise and weight loss have beneficial results on insulin resistance. However, the cause of this benefit remains unclear. We know that both aerobic exercise and/or weight loss can improve how muscle responds to insulin. However, it is also known that aerobic exercise and/or weight loss lowers liver fat content, thereby making it possible that the liver's response to insulin is also improved by weight loss and/or exercise training. An improved responsiveness of the liver to insulin could lower blood sugar levels after a meal and it could also lower morning blood sugar levels. However, very little is known about how exercise and/or weight loss improves liver function in people with type 2 diabetes.
Hypothesis 1: Improved hepatic insulin sensitivity, as a result of either exercise training or weight loss, will increase the amount of glucose from an oral load that is taken up by the liver in subjects with DM. We also hypothesize that the amount of glucose taken up by the liver will be increased even further in response to exercise training plus weight loss compared to either treatment alone.
Hypothesis 2: Increases in hepatic insulin sensitivity as a result of exercise with weight loss will cause reductions in EGP during the fasted state, and will improve the suppression of EGP seen in response to hyperinsulinemia.
| Condition | Intervention |
|---|---|
|
Obesity Type 2 Diabetes |
Behavioral: Aerobic exercise Behavioral: Weight loss |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | The Effect of Exercise on Hepatic Glucose Metabolism in Type 2 Diabetes Mellitus |
- Splanchnic glucose uptake [ Time Frame: 3 years ] [ Designated as safety issue: No ]Improved hepatic insulin sensitivity, as a result of lifestyle intervention, will increase the amount of glucose from an oral load that is taken up by the liver in subjects with DM.
- Endogenous glucose production [ Time Frame: 3 years ] [ Designated as safety issue: No ]Increases in hepatic insulin sensitivity as a result of lifestyle intervention will cause reduced EGP during the fasted state, and in response to hyperinsulinemia. This reduction will be accounted for by reductions in glycogenolysis
| Estimated Enrollment: | 68 |
| Study Start Date: | February 2013 |
| Estimated Study Completion Date: | September 2015 |
| Estimated Primary Completion Date: | September 2015 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Aerobic Exercise
12 weeks of aerobic exercise
|
Behavioral: Aerobic exercise
12 weeks of aerobic exercise with weight maintenance
|
|
Experimental: Weight Loss
12 weeks of low calorie diet to achieve 7-10% weight loss
|
Behavioral: Weight loss
12 weeks of caloric restriction to achieve 7-10% weight loss
|
|
Experimental: Aerobic Exercise with weight loss
12 weeks of aerobic exercise with reduced caloric intake to achieve 7 - 10% weight loss
|
Behavioral: Aerobic exercise
12 weeks of aerobic exercise with weight maintenance
Behavioral: Weight loss
12 weeks of caloric restriction to achieve 7-10% weight loss
|
|
No Intervention: Control
12 weeks with no change in diet or exercise habits (weight maintenance).
|
Eligibility| Ages Eligible for Study: | 40 Years to 60 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 40-60 yrs of age
- sedentary lifestyle
- stable weight
- BMI 30 - 40kg/m2
- Hgb A1c <8.5
- Type 2 diabetes
Exclusion Criteria:
- Use of insulin
- Use of TZDs
Contacts and Locations| United States, Tennessee | |
| Vanderbilt University Medical Center | |
| Nashville, Tennessee, United States, 37232 | |
| Principal Investigator: | Jason Winnick, PhD | Vanderbilt University |
| Study Chair: | Naji Abumrad, MD | Vanderbilt University |
More Information
No publications provided
| Responsible Party: | Jason Winnick, Principal Investigator, Vanderbilt University |
| ClinicalTrials.gov Identifier: | NCT01783275 History of Changes |
| Other Study ID Numbers: | 121031, DK093799 |
| Study First Received: | July 19, 2012 |
| Last Updated: | January 31, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Vanderbilt University:
|
Obesity Type 2 diabetes Liver |
Additional relevant MeSH terms:
|
Diabetes Mellitus Diabetes Mellitus, Type 2 Obesity Glucose Metabolism Disorders Metabolic Diseases Endocrine System Diseases |
Overnutrition Nutrition Disorders Overweight Body Weight Signs and Symptoms |
ClinicalTrials.gov processed this record on May 21, 2013